Halozyme Therapeutics (HALO) PT Raised to $78 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 131.18 +1.15 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.03 | 52 Week High | $18.39 | |||
| Open | $131.06 | 52 Week Low | $6.96 | |||
| Day High | $132.55 | P/E | N/A | |||
| Day Low | $130.09 | EPS | $-0.58 | |||
| Volume | 1,875,452 | |||||
